Management of dysmenorrhea in women with endometriosis

Ilaria Erasmo, Simone Ferrero

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Dysmenorrhea is the most symptoms in women with endometriosis; its intensity is often severe and causes a significant decrease in quality of life. It is often associated with other pain symptoms (such as deep dyspareunia, dyschezia, non-menstrual pelvic pain). The pathogenesis of dysmenorrhea in women with endometriosis remains uncertain; it may be due to nociceptive, inflammatory and neuropathic mechanisms. Two types of therapy for endometriosis-related dysmenorrhea are available: pharmacological therapies that inhibit the growth of the endometriotic implants and surgical therapies, which aim to remove the endometriotic implants. Various hormonal treatments have been shown to effectively and safely relieve pain: non-steroidal anti-inflammatory drugs, progestins, androgens, combined oral contraceptive pill, gonadotropin releasing hormones analogues, gonadotropin releasing hormones antagonists and aromatase inhibitors. Hormonal therapies do not cure endometriosis, therefore patients require a long-term treatment. All hormonal therapies are contraceptive and, therefore, they cannot be administered to patients desiring to conceive. Given this background, the choice of the drug should be based on the preference of the patients, on the incidence of adverse effects and on costs. Surgical excision of endometriosis is a valuable option in patients with severe dysmenorrhea desiring to conceive, in those who have persistence of the symptom despite the administration of hormonal therapies and in those who have contraindications to the use of hormonal therapies. However, dysmenorrhea may recur after surgery if patients do not receive a postoperative hormonal therapy.

Original languageEnglish
Title of host publicationMenorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management
PublisherNova Science Publishers, Inc.
Pages61-83
Number of pages23
ISBN (Print)9781634825832, 9781634825528
Publication statusPublished - Apr 1 2015

Fingerprint

Dysmenorrhea
Endometriosis
Therapeutics
Gonadotropin-Releasing Hormone
Contraceptives, Oral, Combined
Hormone Antagonists
Dyspareunia
Pain
Aromatase Inhibitors
Pelvic Pain
Patient Preference
Progestins
Constipation
Contraceptive Agents
Pharmaceutical Preparations
Androgens
Anti-Inflammatory Agents
Quality of Life
Pharmacology
Costs and Cost Analysis

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Erasmo, I., & Ferrero, S. (2015). Management of dysmenorrhea in women with endometriosis. In Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management (pp. 61-83). Nova Science Publishers, Inc..

Management of dysmenorrhea in women with endometriosis. / Erasmo, Ilaria; Ferrero, Simone.

Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management. Nova Science Publishers, Inc., 2015. p. 61-83.

Research output: Chapter in Book/Report/Conference proceedingChapter

Erasmo, I & Ferrero, S 2015, Management of dysmenorrhea in women with endometriosis. in Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management. Nova Science Publishers, Inc., pp. 61-83.
Erasmo I, Ferrero S. Management of dysmenorrhea in women with endometriosis. In Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management. Nova Science Publishers, Inc. 2015. p. 61-83
Erasmo, Ilaria ; Ferrero, Simone. / Management of dysmenorrhea in women with endometriosis. Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management. Nova Science Publishers, Inc., 2015. pp. 61-83
@inbook{de8693485f7b46e1a00c266455e2232f,
title = "Management of dysmenorrhea in women with endometriosis",
abstract = "Dysmenorrhea is the most symptoms in women with endometriosis; its intensity is often severe and causes a significant decrease in quality of life. It is often associated with other pain symptoms (such as deep dyspareunia, dyschezia, non-menstrual pelvic pain). The pathogenesis of dysmenorrhea in women with endometriosis remains uncertain; it may be due to nociceptive, inflammatory and neuropathic mechanisms. Two types of therapy for endometriosis-related dysmenorrhea are available: pharmacological therapies that inhibit the growth of the endometriotic implants and surgical therapies, which aim to remove the endometriotic implants. Various hormonal treatments have been shown to effectively and safely relieve pain: non-steroidal anti-inflammatory drugs, progestins, androgens, combined oral contraceptive pill, gonadotropin releasing hormones analogues, gonadotropin releasing hormones antagonists and aromatase inhibitors. Hormonal therapies do not cure endometriosis, therefore patients require a long-term treatment. All hormonal therapies are contraceptive and, therefore, they cannot be administered to patients desiring to conceive. Given this background, the choice of the drug should be based on the preference of the patients, on the incidence of adverse effects and on costs. Surgical excision of endometriosis is a valuable option in patients with severe dysmenorrhea desiring to conceive, in those who have persistence of the symptom despite the administration of hormonal therapies and in those who have contraindications to the use of hormonal therapies. However, dysmenorrhea may recur after surgery if patients do not receive a postoperative hormonal therapy.",
author = "Ilaria Erasmo and Simone Ferrero",
year = "2015",
month = "4",
day = "1",
language = "English",
isbn = "9781634825832",
pages = "61--83",
booktitle = "Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management",
publisher = "Nova Science Publishers, Inc.",

}

TY - CHAP

T1 - Management of dysmenorrhea in women with endometriosis

AU - Erasmo, Ilaria

AU - Ferrero, Simone

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Dysmenorrhea is the most symptoms in women with endometriosis; its intensity is often severe and causes a significant decrease in quality of life. It is often associated with other pain symptoms (such as deep dyspareunia, dyschezia, non-menstrual pelvic pain). The pathogenesis of dysmenorrhea in women with endometriosis remains uncertain; it may be due to nociceptive, inflammatory and neuropathic mechanisms. Two types of therapy for endometriosis-related dysmenorrhea are available: pharmacological therapies that inhibit the growth of the endometriotic implants and surgical therapies, which aim to remove the endometriotic implants. Various hormonal treatments have been shown to effectively and safely relieve pain: non-steroidal anti-inflammatory drugs, progestins, androgens, combined oral contraceptive pill, gonadotropin releasing hormones analogues, gonadotropin releasing hormones antagonists and aromatase inhibitors. Hormonal therapies do not cure endometriosis, therefore patients require a long-term treatment. All hormonal therapies are contraceptive and, therefore, they cannot be administered to patients desiring to conceive. Given this background, the choice of the drug should be based on the preference of the patients, on the incidence of adverse effects and on costs. Surgical excision of endometriosis is a valuable option in patients with severe dysmenorrhea desiring to conceive, in those who have persistence of the symptom despite the administration of hormonal therapies and in those who have contraindications to the use of hormonal therapies. However, dysmenorrhea may recur after surgery if patients do not receive a postoperative hormonal therapy.

AB - Dysmenorrhea is the most symptoms in women with endometriosis; its intensity is often severe and causes a significant decrease in quality of life. It is often associated with other pain symptoms (such as deep dyspareunia, dyschezia, non-menstrual pelvic pain). The pathogenesis of dysmenorrhea in women with endometriosis remains uncertain; it may be due to nociceptive, inflammatory and neuropathic mechanisms. Two types of therapy for endometriosis-related dysmenorrhea are available: pharmacological therapies that inhibit the growth of the endometriotic implants and surgical therapies, which aim to remove the endometriotic implants. Various hormonal treatments have been shown to effectively and safely relieve pain: non-steroidal anti-inflammatory drugs, progestins, androgens, combined oral contraceptive pill, gonadotropin releasing hormones analogues, gonadotropin releasing hormones antagonists and aromatase inhibitors. Hormonal therapies do not cure endometriosis, therefore patients require a long-term treatment. All hormonal therapies are contraceptive and, therefore, they cannot be administered to patients desiring to conceive. Given this background, the choice of the drug should be based on the preference of the patients, on the incidence of adverse effects and on costs. Surgical excision of endometriosis is a valuable option in patients with severe dysmenorrhea desiring to conceive, in those who have persistence of the symptom despite the administration of hormonal therapies and in those who have contraindications to the use of hormonal therapies. However, dysmenorrhea may recur after surgery if patients do not receive a postoperative hormonal therapy.

UR - http://www.scopus.com/inward/record.url?scp=84960238039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960238039&partnerID=8YFLogxK

M3 - Chapter

AN - SCOPUS:84960238039

SN - 9781634825832

SN - 9781634825528

SP - 61

EP - 83

BT - Menorrhagia and Dysmenorrhea: Risk Factors, Diagnosis and Management

PB - Nova Science Publishers, Inc.

ER -